Skip to Main Content

Paper Details

IL-36 receptor agonist and antagonist imbalance drives neutrophilic inflammation in COPD.
JCI Insight
8
2022
Author NameAffiliation
Karim C El KasmiBoehringer Ingelheim Pharma GmbH & Co. KG
  • 1 - 1

Datasets

Release 1.2